| Bacillus subtilis (strain 168) |
ATP-dependent Clp protease proteolytic subunit |
Potency |
14125.4 |
nM |
None |
| Bos taurus |
Alpha-1a adrenergic receptor |
Ki |
3.6 |
nM |
10.1021/jm00018a001 |
| Bos taurus |
Alpha-1a adrenergic receptor |
Ki |
200.0 |
nM |
10.1021/jm00375a017 |
| Bos taurus |
Alpha-1a adrenergic receptor |
Ki |
220.0 |
nM |
10.1021/jm00150a002 |
| Bos taurus |
Alpha-1a adrenergic receptor |
Ki |
220.0 |
nM |
10.1021/jm00366a007 |
| Bos taurus |
Alpha-2a adrenergic receptor |
Ki |
49.0 |
nM |
10.1021/jm00150a002 |
| Bos taurus |
Alpha-2a adrenergic receptor |
Ki |
49.0 |
nM |
10.1021/jm00366a007 |
| Bos taurus |
Cerebral cortex alpha adrenergic receptor |
Selectivity ratio |
4.5 |
None |
10.1021/jm00366a007 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Caenorhabditis elegans |
Cytoplasmic zinc-finger protein |
EC50 |
300000.0 |
nM |
None |
| Caenorhabditis elegans |
Zinc finger protein mex-5 |
EC50 |
103486.0 |
nM |
None |
| Cavia porcellus |
Cavia porcellus |
Kd |
12.59 |
nM |
10.1021/jm00106a036 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Electrophorus electricus |
Acetylcholinesterase |
IC50 |
431000.0 |
nM |
10.1021/np960070c |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
14050.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adrenergic receptor alpha-1 |
Kd |
147.91 |
nM |
10.1021/jm00391a015 |
| Homo sapiens |
Adrenergic receptor alpha-1 |
Kd |
794.33 |
nM |
10.1021/jm00129a002 |
| Homo sapiens |
Adrenergic receptor alpha-1 |
Relative potency |
1.0 |
None |
10.1021/jm00391a015 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
8.0 |
nM |
10.1021/jm00390a021 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
36.0 |
nM |
10.1016/j.bmc.2013.03.016 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
58.0 |
nM |
10.1016/j.ejmech.2013.01.044 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
95.0 |
nM |
10.1021/jm058018d |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
170.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
1800.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
195000.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
IC50 |
398000.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
25.7 |
nM |
10.1021/jm00126a042 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
31.62 |
nM |
10.1021/jm00129a002 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
43.65 |
nM |
10.1021/jm00391a015 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
60.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
120.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
2300.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
4800.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
47000.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
62000.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
150000.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Kd |
5400000.0 |
nM |
10.1016/0960-894X(96)00406-4 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
0.4 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
0.6 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
0.9 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
1.8 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
3.0 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
3.8 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
4.0 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
4.1 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
25.0 |
nM |
10.1016/j.ejmech.2013.01.044 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
33.0 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
35.0 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Ki |
70.0 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
pC30 |
8.1 |
None |
10.1021/jm00370a011 |
| Homo sapiens |
Adrenergic receptor alpha-2 |
Selectivity |
44.7 |
None |
10.1021/jm00360a008 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
1202.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
2639.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
6200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Kd |
398.11 |
nM |
10.1021/jm00370a011 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
1057.0 |
nM |
10.1021/jm00019a001 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
10.1021/acs.jmedchem.9b01465 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Inhibition |
90.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
1.1 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
7.2 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
966.0 |
nM |
10.1021/jm00019a001 |
| Homo sapiens |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
10.1021/acs.jmedchem.9b01465 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
1013.0 |
nM |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
1.6 |
nM |
10.1021/jm00018a001 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
289.0 |
nM |
10.1021/jm00019a001 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
498.0 |
nM |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
10.1021/acs.jmedchem.9b01465 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
3.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
5.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
12.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
14.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Activity |
nan |
None |
10.1038/nchembio705 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
EC50 |
8.5 |
nM |
10.1021/np058114h |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
6.151 |
nM |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
8.4 |
nM |
10.1016/j.bmcl.2013.01.025 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Inhibition |
-5.0 |
% |
10.1016/j.bmcl.2013.01.025 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Inhibition |
92.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Inhibition |
nan |
% |
10.1038/nchembio705 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
0.42 |
nM |
10.1016/s0960-894x(00)00068-8 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
1.4 |
nM |
10.1016/j.bmcl.2005.03.116 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
2.307 |
nM |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
3.1 |
nM |
10.1016/j.bmcl.2013.01.025 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
3.1 |
nM |
10.1021/jm990277d |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
3.13 |
nM |
10.1021/acs.jmedchem.9b01465 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
7.5 |
nM |
10.1021/jm00019a001 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
12.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
17.0 |
nM |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Inhibition |
107.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
1.16 |
nM |
10.1021/acs.jmedchem.9b01465 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
2.01 |
nM |
10.1016/s0960-894x(00)00068-8 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
3.2 |
nM |
10.1016/j.bmcl.2013.12.024 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
4.6 |
nM |
10.1021/jm00019a001 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
7.1 |
nM |
10.1016/j.bmcl.2005.03.116 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
7.947 |
nM |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
28.84 |
nM |
10.1016/j.bmcl.2013.12.024 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
3.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
36.0 |
nM |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
0.5 |
nM |
10.1016/j.ejmech.2014.12.045 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
0.5 |
nM |
10.1021/jm401895u |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
0.8 |
nM |
10.1021/acs.jmedchem.9b01465 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
0.88 |
nM |
10.1016/j.bmcl.2005.03.116 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
2.3 |
nM |
10.1021/jm00019a001 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
5.162 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
254000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Inhibition |
35.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB2 receptor |
Inhibition |
20.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 3 |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-C chemokine receptor type 3 |
Inhibition |
-13.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 8 |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-C chemokine receptor type 8 |
Inhibition |
5.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-C chemokine receptor type 8 |
Inhibition |
5.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Cerebroside-sulfatase |
Potency |
2393.4 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-X3-C chemokine receptor 1 |
Inhibition |
22.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-X-C chemokine receptor type 4 |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-X-C chemokine receptor type 4 |
Inhibition |
21.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
C-X-C chemokine receptor type 4 |
Inhibition |
21.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
8.4 |
nM |
10.1021/jm049934e |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
2031.7 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
140.0 |
nM |
10.1021/jm00061a004 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
180.0 |
nM |
10.1021/jm00061a004 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
180.0 |
nM |
10.1021/jm049934e |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
190.0 |
nM |
10.1021/jm00061a004 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
230.0 |
nM |
10.1021/jm00061a004 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
520.0 |
nM |
10.1021/jm00061a004 |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DNA topoisomerase I |
Activity |
nan |
None |
10.1021/np058007n |
| Homo sapiens |
DNA topoisomerase I |
IC50 |
30000.0 |
nM |
10.1021/np058007n |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
2000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
2200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
2909.1 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
188.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
2545.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
2060.0 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
Inhibition |
102.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Dopamine D2 receptor |
Inhibition |
102.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
687.0 |
nM |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
2000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
20000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Dual specificity phosphatase Cdc25A |
IC50 |
22300.0 |
nM |
10.1021/jm300288g |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Follicle stimulating hormone receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Follicle stimulating hormone receptor |
Inhibition |
4.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Formyl peptide receptor 1 |
Inhibition |
-6.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
4100.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucose-dependent insulinotropic receptor |
Inhibition |
8.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
HERG |
AC50 |
29148.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Inhibition |
30.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
19404.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
21192.3 |
nM |
None |
| Homo sapiens |
HL-60 |
Activity |
nan |
None |
10.1021/np058007n |
| Homo sapiens |
HL-60 |
IC50 |
84000.0 |
nM |
10.1021/np058007n |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
IC50 |
1100.0 |
nM |
10.1021/jm00166a009 |
| Homo sapiens |
Importin subunit beta-1/Snurportin-1 |
Potency |
112201.8 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsomes |
CL |
34.4 |
mL.min-1.g-1 |
10.1016/j.bmcl.2011.12.005 |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Inhibition |
4.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide S receptor |
Inhibition |
-3.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
20000.0 |
nM |
10.1021/jm9506433 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Orexin receptor 2 |
Inhibition |
9.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Oxytocin receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Oxytocin receptor |
Inhibition |
5.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
% maximum response |
4.23 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
429.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
501.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_ATPase activity |
1.05 |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_Papp |
1.17 |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prolactin-releasing peptide receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Prolactin-releasing peptide receptor |
Inhibition |
1.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Prolactin-releasing peptide receptor |
Inhibition |
1.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Prostanoid IP receptor |
Inhibition |
8.0 |
% |
10.1021/acs.jmedchem.9b01924 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
2117.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
14689.2 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
66.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
75.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
240.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
644.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1b (5-HT1b) receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Serotonin 1b (5-HT1b) receptor |
Inhibition |
86.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
2400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
6247.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
86.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
260.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
74.0 |
nM |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
47.0 |
nM |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Inhibition |
1.0 |
% |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
AC50 |
691.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
1689.0 |
nM |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
784.0 |
nM |
None |
| Homo sapiens |
Serotonin receptor (2b and 2c) |
Ratio |
83.0 |
None |
10.1021/jm960062t |
| Homo sapiens |
Serotonin transporter |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
33000.0 |
nM |
10.1021/jm00381a019 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
25.6 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Thrombin |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
9441.1 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| Homo sapiens |
Vasopressin V2 receptor |
Inhibition |
-1.0 |
% |
10.1016/j.bmc.2020.115546 |
| Mus musculus |
Alpha-2 adrenergic receptor |
Kd |
10.47 |
nM |
10.1021/jm00371a003 |
| Mus musculus |
Alpha-2 adrenergic receptor |
Ki |
0.6 |
nM |
10.1021/jm00018a001 |
| Mus musculus |
Alpha-2 adrenergic receptor |
Ki |
3.8 |
nM |
10.1021/jm00018a001 |
| Mus musculus |
Alpha-2 adrenergic receptor |
Ki |
54.0 |
nM |
10.1021/jm00018a001 |
| Mus musculus |
Mus musculus |
Activity |
15.8 |
None |
10.1021/jm060743g |
| Mus musculus |
Mus musculus |
Activity |
27.8 |
None |
10.1021/jm060743g |
| Mus musculus |
Mus musculus |
Activity |
28.5 |
None |
10.1021/jm060743g |
| Mus musculus |
Mus musculus |
Activity |
31.7 |
None |
10.1021/jm070161e |
| Mus musculus |
Mus musculus |
Activity |
35.9 |
None |
10.1021/jm060743g |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1016/j.bmc.2012.02.016 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/ml300064v |
| Mus musculus |
Mus musculus |
ED50 |
0.56 |
mg.kg-1 |
10.1021/jm991121g |
| Mus musculus |
Mus musculus |
ED50 |
0.6 |
mg.kg-1 |
10.1021/jm00392a005 |
| Mus musculus |
Mus musculus |
ED50 |
1.23 |
mg.kg-1 |
10.1021/jm991121g |
| Mus musculus |
Mus musculus |
ED50 |
8.0 |
mg.kg-1 |
10.1021/jm9506433 |
| Mus musculus |
Mus musculus |
Response |
nan |
None |
10.1021/jm9506433 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
Serotonin 2c (5-HT2c) receptor |
Ki |
10000.0 |
nM |
10.1021/jm960062t |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Oryctolagus cuniculus |
Kb |
4000.0 |
nM |
10.1021/jm00363a002 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
50000.0 |
nM |
10.1016/j.ejmech.2021.113536 |
| Rattus norvegicus |
Acetylcholinesterase |
IC50 |
nan |
nM |
10.1021/jm9506433 |
| Rattus norvegicus |
Adenosine A2b receptor |
-Log KB |
7.77 |
None |
10.1021/jm960062t |
| Rattus norvegicus |
Adrenergic receptor alpha |
Ratio |
10.0 |
None |
10.1021/jm00402a029 |
| Rattus norvegicus |
Adrenergic receptor alpha |
Selectivity |
4.7 |
None |
10.1021/jm00391a015 |
| Rattus norvegicus |
Adrenergic receptor alpha |
Selectivity index |
-1.11 |
None |
10.1021/jm00370a011 |
| Rattus norvegicus |
Adrenergic receptor alpha |
Selectivity index |
-0.89 |
None |
10.1021/jm00370a011 |
| Rattus norvegicus |
Adrenergic receptor alpha |
Selectivity ratio |
14.0 |
None |
10.1021/jm00366a007 |
| Rattus norvegicus |
Adrenergic receptor alpha |
Selectivity ratio |
32.0 |
None |
10.1021/jm00106a036 |
| Rattus norvegicus |
Adrenergic receptor alpha |
Selectivity ratio |
32.0 |
None |
10.1021/jm00164a021 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
1000.0 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
1300.0 |
nM |
10.1021/jm00370a011 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
IC50 |
1580.0 |
nM |
10.1021/jm991121g |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
7.244 |
nM |
10.1021/jm00360a008 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
89.13 |
nM |
10.1021/jm00391a015 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
263.03 |
nM |
10.1021/jm00402a029 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
302.0 |
nM |
10.1021/jm00366a007 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
302.0 |
nM |
10.1021/jm00371a003 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
302.0 |
nM |
10.1021/jm00375a017 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
323.59 |
nM |
10.1021/jm00360a008 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
346.74 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
616.6 |
nM |
10.1021/jm00348a012 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
630.96 |
nM |
10.1021/jm00143a012 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Kd |
1905.46 |
nM |
10.1021/jm00370a011 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Ki |
360.0 |
nM |
10.1021/jm00158a013 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Ki |
398.11 |
nM |
10.1021/jm00106a036 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Ki |
398.11 |
nM |
10.1021/jm00129a002 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Ki |
398.11 |
nM |
10.1021/jm00164a021 |
| Rattus norvegicus |
Adrenergic receptor alpha-1 |
Ratio |
0.032 |
None |
10.1021/jm00143a012 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
AD50 |
1.04 |
mg kg-1 |
10.1021/jm00366a007 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
9.1 |
nM |
10.1021/jm00126a042 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
30.0 |
nM |
10.1021/jm960087s |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
30.0 |
nM |
10.1021/jm9604538 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
58.0 |
nM |
10.1016/j.bmc.2010.07.034 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
67.0 |
nM |
10.1021/jm991121g |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
96.0 |
nM |
10.1016/j.bmc.2016.03.006 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
96.0 |
nM |
10.1016/j.bmc.2016.11.014 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
IC50 |
165.0 |
nM |
10.1021/jm00370a011 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
ID50 |
0.185 |
mg.kg-1 |
10.1021/jm00106a036 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
ID50 |
2.8 |
mg.kg-1 |
10.1021/jm00106a036 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
12.3 |
nM |
10.1021/jm00391a034 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
12.3 |
nM |
10.1021/jm00392a005 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
19.05 |
nM |
10.1021/jm00391a015 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
19.5 |
nM |
10.1021/jm00348a012 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
19.95 |
nM |
10.1021/jm00143a012 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
22.39 |
nM |
10.1021/jm00366a007 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
22.39 |
nM |
10.1021/jm00375a017 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
25.7 |
nM |
10.1021/jm00391a015 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
26.3 |
nM |
10.1021/jm00402a029 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
123.03 |
nM |
10.1021/jm00392a005 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Kd |
147.91 |
nM |
10.1021/jm00370a011 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
0.6 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
1.0 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
2.4 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
5.0 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
8.7 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
10.0 |
nM |
10.1021/jm00150a002 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
12.59 |
nM |
10.1021/jm00106a036 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
12.59 |
nM |
10.1021/jm00129a002 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
12.59 |
nM |
10.1021/jm00164a021 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
45.0 |
nM |
10.1021/jm00158a013 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
48.0 |
nM |
10.1021/jm00158a013 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
52.0 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
54.0 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
56.23 |
nM |
10.1021/jm00164a021 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
78.0 |
nM |
10.1021/jm00391a034 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
84.0 |
nM |
10.1021/jm00392a005 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
104.0 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
150.0 |
nM |
10.1021/jm00354a001 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ki |
190.0 |
nM |
10.1021/jm00392a005 |
| Rattus norvegicus |
Adrenergic receptor alpha-2 |
Ratio |
0.2 |
None |
10.1021/jm00164a021 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
1235.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
500.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
1188.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
658.0 |
nM |
None |
| Rattus norvegicus |
Alpha-1d adrenergic receptor |
Ki |
52.0 |
nM |
10.1021/jm00018a001 |
| Rattus norvegicus |
Alpha-2b adrenergic receptor |
Ki |
2.0 |
nM |
10.1021/jm990277d |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Dopamine D2 receptor |
IC50 |
1125.0 |
nM |
10.1021/jm991121g |
| Rattus norvegicus |
Dopamine D3 receptor |
Ki |
2430.0 |
nM |
10.1021/jm00062a025 |
| Rattus norvegicus |
Dopamine receptor |
Ki |
2000.0 |
nM |
10.1021/jm00158a013 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor |
IC50 |
nan |
nM |
10.1021/jm9506433 |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1.04 |
mg.kg-1 |
10.1021/jm00150a002 |
| Rattus norvegicus |
Rattus norvegicus |
ID50 |
0.185 |
mg.kg-1 |
10.1021/jm00129a002 |
| Rattus norvegicus |
Rattus norvegicus |
ID50 |
2.8 |
mg.kg-1 |
10.1021/jm00129a002 |
| Rattus norvegicus |
Rattus norvegicus |
Kd |
22.39 |
nM |
10.1021/jm00150a002 |
| Rattus norvegicus |
Rattus norvegicus |
Kd |
302.0 |
nM |
10.1021/jm00150a002 |
| Rattus norvegicus |
Rattus norvegicus |
Ki |
505.0 |
nM |
10.1021/jm00054a005 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
126.0 |
nM |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
72.0 |
nM |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 2a (5-HT2a) receptor |
Ki |
1621.81 |
nM |
10.1021/jm960062t |
| Rattus norvegicus |
Serotonin 2a (5-HT2a) receptor |
-Log KB |
6.37 |
None |
10.1021/jm960062t |
| Rattus norvegicus |
Serotonin 2b (5-HT2b) receptor |
Inhibition |
nan |
% |
10.1007/s00044-005-0125-z |
| Rattus norvegicus |
Serotonin 2b (5-HT2b) receptor |
-Log KB |
6.92 |
None |
10.1021/jm960062t |
| Rattus norvegicus |
Serotonin 2b (5-HT2b) receptor |
pKb |
7.74 |
None |
10.1007/s00044-005-0125-z |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
Ki |
45.0 |
nM |
10.1021/jm00019a001 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
23109.3 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Sus scrofa |
Alpha-2a adrenergic receptor |
Ki |
4.4 |
nM |
10.1021/jm00018a001 |
| None |
ADMET |
Binding energy |
11.9 |
kCal mol-1 |
10.1021/jm00378a021 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
No relevant target |
LogD7.4 |
1.65 |
None |
10.6019/CHEMBL3301361 |
| None |
No relevant target |
Log Kmemb |
0.5 |
None |
10.1021/jm0309001 |
| None |
Unchecked |
Ac50 |
0.631 |
uM |
None |
| None |
Unchecked |
Ac50 |
0.7079 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
631.0 |
nM |
None |
| None |
Unchecked |
AC50 |
707.9 |
nM |
None |
| None |
Unchecked |
AC50 |
39810.7 |
nM |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmc.2020.115546 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np058007n |
| None |
Unchecked |
EC50 |
110000.0 |
nM |
None |
| None |
Unchecked |
Hill coefficient |
0.97 |
None |
10.1021/jm00062a025 |
| None |
Unchecked |
IC50 |
38.0 |
nM |
10.1021/jm701575k |
| None |
Unchecked |
IC50 |
100.0 |
nM |
10.1021/jm8007618 |
| None |
Unchecked |
IC50 |
157.0 |
nM |
None |
| None |
Unchecked |
IC50 |
125000.0 |
nM |
10.1021/np058007n |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
-3.0 |
% |
10.1016/j.bmc.2020.115546 |
| None |
Unchecked |
Kb |
100.0 |
nM |
10.1016/j.bmc.2008.02.091 |
| None |
Unchecked |
Kb |
300.0 |
nM |
10.1016/j.bmc.2008.02.091 |
| None |
Unchecked |
Ki |
33.0 |
nM |
10.1021/jm2006782 |
| None |
Unchecked |
Ki |
43.0 |
nM |
10.1021/jm8007618 |
| None |
Unchecked |
Ki |
49.0 |
nM |
10.1021/jm00375a017 |
| None |
Unchecked |
Ki |
105.0 |
nM |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
316.2 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Ratio |
13.5 |
None |
10.1021/jm960062t |
| None |
Unchecked |
Ratio |
15.0 |
None |
10.1021/jm00129a002 |
| None |
Unchecked |
Ratio |
29.0 |
None |
10.1021/jm00371a003 |
| None |
Unchecked |
Selectivity |
4.8 |
None |
10.1016/s0960-894x(00)00068-8 |
| None |
Unchecked |
Selectivity |
14.0 |
None |
10.1021/jm00150a002 |
| None |
Unchecked |
Selectivity |
22.0 |
None |
10.1021/jm00150a002 |
| None |
Unchecked |
Selectivity |
25.0 |
None |
10.1021/jm00129a002 |
| None |
Unchecked |
Selectivity |
32.0 |
None |
10.1021/jm00129a002 |
| None |
Unchecked |
Selectivity index |
-1.7 |
None |
10.1021/jm00370a011 |
| None |
Unchecked |
Selectivity ratio |
4.5 |
None |
10.1021/jm00375a017 |
| None |
Unchecked |
Selectivity ratio |
14.0 |
None |
10.1021/jm00375a017 |
| None |
Unchecked |
Selectivity ratio |
31.6 |
None |
10.1021/jm00348a012 |